Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph G Schroers-Martin

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Hematology. American Society of Hematology. Education Program|December 7, 2024
When should we use it? The role of brentuximab vedotin in 2024Joseph G Schroers-Martin, Ranjana Advani
JCO Oncology Practice|September 12, 2024
Integrating Novel Agents Into the Clinical Management of Classic Hodgkin LymphomaJoseph G Schroers-Martin, Ranjana Advani
Clinical Lymphoma, Myeloma & Leukemia|June 4, 2026
Early Stage Hodgkin Lymphoma-Are We Ready for Novel Agents?Joseph G Schroers-Martin, Ranjana Advani
JCO Oncology Practice|November 12, 2024
Cell-Free DNA in Hematologic MalignanciesJoseph G Schroers-Martin, Ash A Alizadeh
Seminars in Hematology|July 14, 2024
The role of response adapted therapy in the era of novel agentsJoseph G Schroers-Martin, Ranjana H Advani
Annual Review of Pathology|September 21, 2022
Molecular Monitoring of LymphomasJoseph G Schroers-Martin, Stefan Alig, Andrea Garofalo, et al.
Haematologica|July 2, 2026
Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphomaJoseph G Schroers-Martin, Reid Merryman, Michael A Spinner, et al.
Cell Stem Cell|February 25, 2024
A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironmentJenna M Kastenschmidt, Joseph G Schroers-Martin, Brian J Sworder, et al.
Cancer Discovery|March 20, 2023
Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma PrecursorsJoseph G Schroers-Martin, Joanne Soo, Gabriel Brisou, et al.
Blood Cancer Discovery|January 11, 2022
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished ImmunityTanaya Shree, Vishnu Shankar, Julian J K Lohmeyer, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Hematology. American Society of Hematology. Education Program|December 7, 2024
When should we use it? The role of brentuximab vedotin in 2024Joseph G Schroers-Martin, Ranjana Advani
JCO Oncology Practice|September 12, 2024
Integrating Novel Agents Into the Clinical Management of Classic Hodgkin LymphomaJoseph G Schroers-Martin, Ranjana Advani
Clinical Lymphoma, Myeloma & Leukemia|June 4, 2026
Early Stage Hodgkin Lymphoma-Are We Ready for Novel Agents?Joseph G Schroers-Martin, Ranjana Advani
JCO Oncology Practice|November 12, 2024
Cell-Free DNA in Hematologic MalignanciesJoseph G Schroers-Martin, Ash A Alizadeh
Seminars in Hematology|July 14, 2024
The role of response adapted therapy in the era of novel agentsJoseph G Schroers-Martin, Ranjana H Advani
Annual Review of Pathology|September 21, 2022
Molecular Monitoring of LymphomasJoseph G Schroers-Martin, Stefan Alig, Andrea Garofalo, et al.
Haematologica|July 2, 2026
Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphomaJoseph G Schroers-Martin, Reid Merryman, Michael A Spinner, et al.
Cell Stem Cell|February 25, 2024
A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironmentJenna M Kastenschmidt, Joseph G Schroers-Martin, Brian J Sworder, et al.
Cancer Discovery|March 20, 2023
Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma PrecursorsJoseph G Schroers-Martin, Joanne Soo, Gabriel Brisou, et al.
Blood Cancer Discovery|January 11, 2022
CD20-Targeted Therapy Ablates De Novo Antibody Response to Vaccination but Spares Preestablished ImmunityTanaya Shree, Vishnu Shankar, Julian J K Lohmeyer, et al.
Pageof 2